MTIM
ACHN

Marathon Trading Investment Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Marathon Trading Investment Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-34,600
Closed -$424K – 651
2014
Q4 		$424K Buy
+34,600
New +$423K 0.01% 437

Other funds holding ACHN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marathon Trading Investment Management's ACHN Position: Q1 2015 in Review

Marathon Trading Investment Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2015, closing a stake of 34,600 shares — an estimated $424K sold.

Marathon Trading Investment Management first reported a position in ACHN in Q4 2014 and held it in 1 quarter. The position peaked at $424K in Q4 2014. 173 funds tracked by Wall St. Rank hold ACHN as of Q1 2015.

  • Marathon Trading Investment Management reported no remaining Achillion Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Marathon Trading Investment Management sold 34,600 Achillion Pharmaceuticals shares in Q1 2015, an estimated $424K.
  • Marathon Trading Investment Management first reported a position in Achillion Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • Marathon Trading Investment Management's Achillion Pharmaceuticals position peaked at $424K in Q4 2014.
  • 173 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2015.

Based on Marathon Trading Investment Management's 13F filing for Q1 2015, filed 12 May 2015.